NYSEARCA:LDRS Innovator IBD ETF Leaders ETF (LDRS) Price, Holdings, & News $28.27 -0.15 (-0.53%) As of 08/13/2021 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Innovator IBD ETF Leaders ETF (NYSEARCA:LDRS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LDRS alerts:Sign Up Key Stats Today's Range$28.24▼$28.2750-Day Range$28.27▼$28.2752-Week Range$23.43▼$29.77Volume1,700 shsAverage Volume2,574 shsMarket Capitalization$8.48 millionAssets Under Management$8.53 millionDividend Yield0.07%Net Expense Ratio1.16%Aggregate RatingN/A ETF Overview Read More Innovator IBD ETF Leaders ETF ExpensesTypeLDRSAlpha-Seeking ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.61%0.56%0.51%0.53%Other Expenses0.56%0.51%0.56%0.59%0.56%Total Expense1.16%0.94%0.76%0.74%0.73%Fee Waiver0.00%-0.31%-0.66%-0.71%-0.63%Net Expense1.16%0.86%0.63%0.58%0.60% Receive LDRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovator IBD ETF Leaders ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address LDRS ETF News HeadlinesThese IBD 50 Leaders Melt Gains As Stock Market WaversNovember 2, 2024 | msn.comFirst Trust New Cstrcts Cr Erns Ldrs ETFOctober 5, 2024 | morningstar.comMI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.July 18 at 2:00 AM | Timothy Sykes (Ad)Innovator Nasdaq100 Managed Floor Etf Share Price (QFLR.US)August 5, 2024 | lse.co.ukInnovator Equity Defined Protection ETF - 1 Yr JulyJuly 24, 2024 | barrons.comInnovator IBD ETF Leaders ETF (LDRS)February 22, 2024 | finance.yahoo.comSee More Headlines LDRS ETF - Frequently Asked Questions How have LDRS shares performed this year? Innovator IBD ETF Leaders ETF's stock was trading at $28.27 on January 1st, 2025. Since then, LDRS stock has increased by 0.0% and is now trading at $28.27. How do I buy shares of Innovator IBD ETF Leaders ETF? Shares of LDRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Innovator IBD ETF Leaders ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD ETF Leaders ETF investors own include BILL (BILL), Global X Robotics & Artificial Intelligence ETF (BOTZ), Carvana (CVNA), Datadog (DDOG), Fastly (FSLY), Luckin Coffee (LKNCY) and Eli Lilly and Company (LLY). Fund Details IssuerInnovator Capital Management Fund NameInnovator IBD ETF Leaders ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LDRS Inception Date12/21/2017 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIBD ETF Leaders Index CategoryStrategy FocusAlpha-Seeking Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$8.53 million Average Daily Volume$746.30 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorInnovator Capital Management, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares300,000BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NYSEARCA:LDRS) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD ETF Leaders ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD ETF Leaders ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
